Clinical characteristics, antimicrobial resistance, and mortality of neonatal bloodstream infections in Northern Tanzania, 2022–2023
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0319816 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Ganga S Moorthy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacteremia, Neonatal Sepsis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Neonatal bloodstream infections (BSI) make a substantial contribution to morbidity and mortality in low- and middle-income countries (LMICs), but data on the epidemiology and antimicrobial resistance (AMR) in Tanzania are limited. We describe the prevalence, resistance patterns, and associated factors of neonatal BSI at the Kilimanjaro Christian Medical Centre (KCMC), a large referral hospital in northern Tanzania. We conducted a prospective, observational study involving infants aged 0–60 days with perinatal risk factors or clinical signs of sepsis. Aerobic blood cultures were obtained at enrollment and monitored using a continuously monitored blood culture instrument. Antimicrobial susceptibility testing was performed using standard phenotypic methods. Vital status was obtained on days 2, 7, and 28 post-enrollment. BSI was defined as the isolation of established neonatal pathogens, including yeast and coagulase-negative Staphylococcus spp. (CoNS). Early-onset BSI occurred on day of life (DOL) 0-2, while late-onset BSI occurred on DOL 3 or later. Among 236 enrolled infants, blood culture was obtained in 233. BSI occurred in 106 (45.5%) of 233 infants, 50 (47.2%) were early-onset, and 56 (52.8%) were late-onset BSI. The isolated pathogens included 58 (54.7%) Gram-positive bacteria, 40 (37.7%) Gram-negative bacteria, and 8 (7.5%) yeast. CoNS (n = 55, 51.9%) and Klebsiella pneumoniae (n = 35, 33.0%) were the most common pathogens. Notably, all K. pneumoniae isolates were extended-spectrum beta-lactamase producers, resistant to ampicillin and ceftriaxone. Among the 56 infants who died, 29 (51.8%) had BSI; 11 (19.6%) infants with EO-BSI, and 18 (32.1%) with LO-BSI. Infants requiring respiratory support at admission had a 1.89-fold increased adjusted odds of BSI (95% CI, 1.05-3.44). We found high prevalence of neonatal BSI due to bacteria with a high prevalence of AMR, and BSI was associated with high mortality. There is an urgent need for effective preventive, diagnostic, and therapeutic interventions to address BSI among hospitalized infants in northern Tanzania.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
- Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
- Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America.
- Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania.
- Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, SingaporeSingapore.
- Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
ORCID-Profile: Ganga S Moorthy, Ronald Mbwasi, John A Crump, Blandina T Mmbaga, Aisa Shayo
Förderung
- FIC NIH HHS
- NIAID NIH HHS
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Fogarty International Center
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Moorthy, G. S., Rubach, M. P., Sechu, A., Mbwasi, R., Peter, N., Kalu, I. C., Crump, J. A., Dow, D. E., Mmbaga, B. T., & Shayo, A. (2025). Clinical characteristics, antimicrobial resistance, and mortality of neonatal bloodstream infections in Northern Tanzania, 2022–2023. PLOS ONE. https://doi.org/10.1371/journal.pone.0319816
Vancouver
Moorthy GS, Rubach MP, Sechu A, Mbwasi R, Peter N, Kalu IC, et al. Clinical characteristics, antimicrobial resistance, and mortality of neonatal bloodstream infections in Northern Tanzania, 2022–2023. PLOS ONE. 2025. doi:10.1371/journal.pone.0319816
BibTeX
@article{Moorthy2025,
author = {Moorthy, Ganga S and Rubach, Matthew P and Sechu, Anna and Mbwasi, Ronald and Peter, Nyemo and Kalu, Ibukunoluwa C and Crump, John A and Dow, Dorothy E and Mmbaga, Blandina T and Shayo, Aisa},
title = {Clinical characteristics, antimicrobial resistance, and mortality of neonatal bloodstream infections in Northern Tanzania, 2022–2023},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0319816}
}
EUVIMED